epidermal-growth-factor and Asphyxia-Neonatorum

epidermal-growth-factor has been researched along with Asphyxia-Neonatorum* in 3 studies

Other Studies

3 other study(ies) available for epidermal-growth-factor and Asphyxia-Neonatorum

ArticleYear
Urinary excretion of human epidermal growth factor in premature infants requiring assisted ventilation over the first week of life.
    Nephron, 1997, Volume: 76, Issue:2

    Topics: Apgar Score; Asphyxia Neonatorum; Epidermal Growth Factor; Humans; Infant, Newborn; Infant, Premature; Respiration, Artificial; Respiratory Distress Syndrome, Newborn

1997
Effect of asphyxia on urinary epidermal growth factor levels in newborns.
    Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 1997, Volume: 17, Issue:3

    Urinary epidermal growth factor (EGF) excretion in normal newborn as well as neonates with asphyxia was investigated by using radioimmunoassay, and serum creatinine (Scr) levels determined at the same time. The results showed that in severe asphyxia group the ratio of urinary EGF to urinary creatinine (Cr) (EGF/Cr), an index reflecting EGF excretion, was decreased on the first day (P < 0.05) and reached the lowest level on the third day (P < 0.01). However, EGF/Cr values were decreased only on the third day in neonates with mild asphyxia (P < 0.05). On the seventh day, EGF/Cr values of neonates with asphyxia rose to normal. There were a negative correlation between urinary EGF/Cr and Scr. It is suggested that EGF may play a role in the repair of acute renal injury after asphyxia and the detection of urinary EGF concentration is useful in the judgment of severity of renal injury and in the evaluation of the recovery of renal tubule after injury.

    Topics: Acute Kidney Injury; Asphyxia Neonatorum; Biomarkers; Creatinine; Epidermal Growth Factor; Female; Humans; Infant, Newborn; Male

1997
Maturational changes and origin of urinary human epidermal growth factor in the neonatal period.
    Biology of the neonate, 1989, Volume: 56, Issue:5

    In order to clarify the characteristics of urinary human epidermal growth factor (hEGF) excretion in the newborn period, we examined hEGF in the 41 newborn infants; 12 healthy preterm infants (group A), 10 healthy full-term infants (group B), 12 full-term infants with neonatal asphyxia (group C), 7 full-term infants treated with tobramycin (group D) during the first week of life. Renal function tests, i.e. creatinine clearance (Ccr), and N-acetyl-beta-D-glucosaminidase (NAG) as a parameter of renal tubular damage, were examined in 29 full-term infants. Urinary hEGF excretion showed a linear increase with gestational age. During the first week of life, urinary hEGF excretion in group B increased with age. However, urinary hEGF excretion in group A remained at the constant level through the study period. Ccr in group C was significantly decreased through the study period when compared with that in group B. NAG indices in group C during the first week of life and those in group D on days 5-7 of life were more elevated than those in group B. Urinary hEGF excretion in group C on days 4-7 of life and that in group D on day 7 of life were significantly decreased when compared with that in group B. These results suggest that urinary hEGF excretion is related to the maturation and that the source of urinary hEGF may be renal tubular cells.

    Topics: Age Factors; Asphyxia Neonatorum; Birth Weight; Epidermal Growth Factor; Female; Humans; Infant, Newborn; Infant, Premature; Kidney Function Tests; Male; Tobramycin

1989